If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
174.50    -1.80 (-1.02%)
Bid:
175.60
Ask:
175.80
Spread: 0.20 (0.114%)
Market Cap: £1.29b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Acquisition

23 Jun 2022 07:00

RNS Number : 8818P
Grainger PLC
23 June 2022
 

23 June 2022

Grainger plc 

("Grainger", the "Company", the "Group")

 

Acquisition

Grainger agrees to acquire its third build-to-rent investment in Bristol for £128m

 

Grainger plc, the UK's largest listed residential landlord with 9,793 operational rental homes and a further 9,962 build-to-rent homes in its £2.4bn pipeline, today announces that it has exchanged conditional contracts to forward fund and acquire the build-to-rent element of the second phase of 'Redcliff Quarter' in Bristol which comprises 374 private rental (PRS) homes, as well as 94 affordable homes and six commercial units.

 

Grainger has agreed to acquire the scheme from Redcliff MCC LLP, backed by ICG Real Estate in partnership with Madison Cairn. Winvic Construction Limited has been appointed as contractor for the scheme. Winvic built Grainger's Brook Place development in Sheffield and is also delivering the Copper Works in Cardiff for Grainger.

 

In addition to the 374 PRS homes and 94 affordable homes at Redcliff Quarter, the scheme includes a total of c.5,900 sq. ft of internal residents' amenity space; c.21,200 sq. ft of external amenity space; c.8,500 sq. ft of commercial space; and 31 car parking spaces. A further six commercial units totalling c.15,800 sq. ft have also been acquired as part of the transaction.

 

The site is located within the central Redcliffe district of Bristol and forms part of the second and final phase of 'Redcliff Quarter', a wider residential-led, mixed use masterplan development.  The scheme is a nine-minute walk from Bristol Temple Meads rail station.

 

Construction is expected to commence in Q3 2022, with practical completion of the final element targeted for early 2025. It is anticipated that the scheme, including the commercial element, will generate a gross yield on cost of c.6% once fully let and stabilised.

 

In line with Grainger's cluster strategy, Redcliff Quarter builds on Grainger's existing Bristol portfolio, which includes Hawkins & George, comprising 194 build-to-rent homes, and Millwrights Place which will comprise 231 build-to-rent homes when complete in early 2024.

Helen Gordon, Chief Executive Officer of Grainger, said:

 

"We are very pleased to acquire our third build-to-rent scheme in Bristol which will further strengthen our city cluster, bringing our total investment in the city to nearly 900 homes when complete and driving operational efficiencies, whilst also enabling us to deliver 94 new affordable homes via Grainger Trust, our in-house affordable housing arm."

 

 

-ENDS-

For further information:

Grainger plc

Helen Gordon/ Rob Hudson / Kurt Mueller

London Office Tel: +44 (0) 20 7940 9500

Newcastle Office Tel: +44 (0) 191 261 1819

 

Camarco (Grainger PR)

Ginny Pulbrook / Geoffrey Pelham Lane

Tel: +44 (0) 20 3757 4992/4985

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSEWEEEEESEEM
Date   Source Headline
4th Apr 202310:25 amRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSNotice of Results
13th Mar 202311:57 amRNSTotal Voting Rights
7th Mar 202312:46 pmRNSDirector/PDMR Shareholding
15th Feb 20231:35 pmRNSDirector/PDMR Shareholding
8th Feb 20234:16 pmRNSResult of AGM
8th Feb 20237:00 amRNSTrading Update
7th Feb 202312:12 pmRNSDirector/PDMR Shareholding
7th Feb 202312:08 pmRNSDirector/PDMR Shareholding
6th Feb 20233:14 pmRNSTotal Voting Rights
20th Jan 20235:12 pmRNSAGM Statement
12th Jan 202312:16 pmRNSTotal Voting Rights
10th Jan 20232:33 pmRNSDirector/PDMR Shareholding
13th Dec 20221:49 pmRNSDirector/PDMR Shareholding
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company
18th Feb 202211:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.